Cyban Pty Ltd

We’re pleased to announce that we’ve been invited to present at the upcoming American Heart Association conference! Join us for an enlightening presentation by Cyban Pty Ltd's ICU Clinical Trials Researcher, Dr. Sigrid Petautschnig - Non-Invasive Optical Brain Pulse Monitoring in High-Risk Cardiac Surgery. 📅 Date: November 17, 2024 ⏱ Time: 11:30 AM Discover the latest advancements in stroke surveillance research! #StrokeResearch #CognitiveHealth #HealthcareInnovation #AmericanHeartAssociation #ClinicalTrials #MedicalAdvancements #AHA2024 #Cyban

NEWS ALERT - The Australian Business Journal Article - Improving the Health Industry: Exclusive Interview with Dr. Mary-Beth Brinson. Read the full article here - https://lnkd.in/gNJ4fw6y

Cyban is thrilled to welcome Steve Motes as our new Chief Strategy Officer for the USA. With over 20 years of experience leading high-performing teams and a strong track record in global marketing and commercialization, Steve brings a wealth of expertise to our organization. Steve's deep understanding of the industry, familiarity with key professionals, and insight into the challenges of previous product portfolios make him an invaluable addition to our team. His enthusiasm for our innovative wave technology and his vision for expanding the US market are particularly inspiring. Steve's background aligns perfectly with Cyban's mission. He most recently served as the CEO at Vascular Graft Solutions, where he led an Israeli company whilst navigating complex funding and regulatory landscapes. Before that, Steve held leadership roles at several large MedTech companies such as Abbott, Edwards Lifesciences, Dräger and Somanetics, now part of Medtronic. During his time at Somanetics, Steve was pivotal in establishing the early adoption of noninvasive technology for monitoring cerebral and somatic tissue perfusion, which is now a standard of care in cardiac surgery and its broader application in the ICUs. We are confident that Steve's strategic vision and leadership will drive Cyban's growth and success in the US market. He will officially join us on July 29, 2024, and we look forward to the innovative and dynamic contributions he will bring to our team. Please join us in welcoming Steve to Cyban!

Cyban is hiring!! We're on the hunt for an exceptional Chief Operating Officer (Medical) to join our team! Find out more on the below link.

We are delighted to share a photo from the 18th Biotech Summit held on July 12th & 13th, 2024 in Fremantle, WA! Dr. Mary-Beth Brinson captivated the audience with her presentation on our next-generation brain pulse monitor. Attendees were excited to learn about the latest advancements in brain health insights. Thank you to everyone who joined us and made the event a success! #BiotechSummit2024 #Cyban #BrainHealth #Innovation #TechInHealth

We're thrilled to announce that Dr. Mary-Beth Brinson will be speaking at the 18th Biotech Summit on July 12th & 13th, 2024 in Fremantle, WA! Don't miss this opportunity to learn about Cyban's latest advancements in brain pulse monitoring! #BiotechSummit2024 #Cyban #BrainHealth #Innovation

Brain Monitoring Market Worth $4.8 Billion by 2028 𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗣𝗗𝗙 𝗕𝗿𝗼𝗰𝗵𝘂𝗿𝗲-https://lnkd.in/dwppqatB The global brain monitoring market in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $4.8 billion by 2028, growing at a CAGR of 6.3% from 2023 to 2028 𝗧𝗼𝗽 𝗖𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗶𝗻 𝗠𝗮𝗿𝗸𝗲𝘁 Ceribell │ AI-Powered Point-of-Care EEG    Neuroelectrics   Natus Newborn Care SOPHYSA Immuno-Biological Laboratories, Inc. (IBL-America) Bearmind  Cerenion Oy    ICONEUS      Neurosteer  Neurostar  NeuroWave Systems Inc. BrainSpace  Sonovum   CranioSense  Cyban Pty Ltd  JuneBrain Inc.      AiimSense   Natus Hearing & Balance Italia PIONIRS  ParagonCare | REM SYSTEMS Australia     Inoko Vision Neurolite AG   iFocus Health  Channels Neuro Welcony

Last week, #Cyban had the privilege of attending the #ACMD delirium workshop. This event, organised by the Aikenhead Centre for Medical Discovery (ACMD), brought together leading minds in MedTech research, teaching, and commercialisation. The ACMD, led by St Vincent's Hospital Melbourne (SVHM), is a collaboration of 8 partners including the St Vincent's Institute of Medical Research, Bionics Institute, Centre for Eye Research Australia (CERA), University of Melbourne, RMIT University, Swinburne University of Technology, and Australian Catholic University. Together, they are creating a globally leading MedTech hub right in the clinical setting. We were thrilled, enthusiastic and excited to be invited to attend the workshop. Here is to many more to follow! #Medtech #Health #BrainHealth #Innovation #Research | Jacqui Savage | Sigrid Petautschnig | Mary-Beth Brinson 

Cyban Pty Ltd CEO Dr Mary-Beth Brinson recently joined Andrew Musgrave on the ASX Briefs podcast to discuss our patented brain pulse monitor and the trajectory of our company. Designed to be non-invasive, bilateral and to provide continuous information on blood flow in the brain, #Cyban’s brain pulse monitor is purposed for giving clinicians the earliest possible indication that a patient is declining, allowing early intervention and improving patient outcomes. From its birth in St. Vincent’s Hospital Melbourne to a current, pending FDA application, our brain pulse monitor has come a long way. Dr Brinson said that Cyban has partnered with world-leading centres of excellence such as Duke University and Cleveland Clinic to build a sound clinical foundation for the monitor. Through trial studies, we have seen tangible patient benefits that our product has the potential to deliver, and the projected economic savings it is poised to achieve for the healthcare system.  Listen to the full episode in the link below. #novelmedicaldevice #brainpulsemonitor #MedTech

Cyban Pty Ltd CEO, Dr Mary-Beth Brinson is pleased to announce that she will be presenting at the MedInvest Medtech, AI and Digital Health Conference in San Francisco, 11 June at 1.40pm on how Cyban is advancing the way brain injuries are detected and managed. Agenda: https://bit.ly/4cbMCBm To learn more about #Cyban's brain monitoring capabilities or if you are interested in meeting Mary Beth in-person or online, reach out via info@cyban.com.au #MedInvest #Brainmonitoring #Healthcare #Investor